Lesley Taylor

Lesley Taylor

Auto-generated profile, based on publicly available information

Lesley Taylor

Department of Surgery, City of Hope National Medical Center, Duarte, CA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2023 in JCO Global Oncology
Verified
Journal Article
Open access
NBNetsanet Bogale
Netsanet Bogale
BBBargude Balta
Bargude Balta
GDGulema Demissie
Gulema Demissie
DGDereje Geleta
Dereje Geleta
MRMichele Rakoff
Michele Rakoff
LTLesley Taylor
Lesley Taylor
PURPOSE: The aim of this study was to explore breast cancer (BC) challenges to identify opportunities for advocacy in southern Ethiopia in 2022. METHODS: Twenty-five participants from four local districts (kebeles) in Hawassa City were selected as key contributors to future work. Semistructured in-depth interviews were held for two clinicians, two local health bureau managers, two media managers, and three religious leaders. Two focus group discussions were conducted: one included six BC survivors and a caregiver; the other included two health extension workers, three members of the Women's Development Group, two community volunteers, one kebele leader, and one traditional healer. RESULTS: To our knowledge, our study was the first time that most participants had assembled. Many referred to patients as victims and BC as a killer disease or curse. Community and religious leaders were concerned about challenges and willing to collaborate. Survivors, providers, and religious leaders were identified as key sources of information, positive messages, and leadership. CONCLUSION: Recommendations for advocacy work in Hawassa include lobbying for BC as a health priority; including BC within the health extension package; initiating programs for earlier detection; educating the community to remove stigmas of the disease and treatments; working with media to disseminate messages that are inclusive of people in remote areas and speaking different languages; improving availability, affordability, and access to care; and assisting patients with psychosocial support. A strategic collaboration between religious leaders and health care providers was identified to increase community awareness and support advocacy for patients.

3 January 2024 in BMC Cancer
Verified
Journal Article
Open access
PDF file
LSLinda Setiawan
Linda Setiawan
KGKaty Graef
Katy Graef
DSDan Schmolze
Dan Schmolze
AAAlemwosen Alem
Alemwosen Alem
LTLesley Taylor
Lesley Taylor
To address the need for a skilled workforce in breast cancer (BC) pathology in sub-Saharan Africa (SSA), we implemented an education program to train laboratory technicians in manual immunohistochemistry (IHC). A quality improvement education project was developed. Interactive webinars were held every six months with didactics and presentations from African experts with experience in IHC. We conducted knowledge assessments and surveys on current practice, equipment, and human resources. A digital mentorship platform (DMP) was created for discussions, sharing SOPs, and networking. For one year (2022–2023), we followed developments in pathology capacity, practice changes, and educational needs. A paired t-test was used to calculate the significance of changes in knowledge immediately after the webinar and comfort level with topics 35 days after the webinar. Two hundred and sixty six participants from 10 SSA countries attended the first webinar, a series of six lectures on IHC theory, methods, and practice. Ninety-five participants from nine SSA countries provided a baseline assessment of pathology capacity and feedback. Mean knowledge increased by 17.4% immediately after the webinar (from 41.8% pre-webinar to 59.2% post, p = < 0.0001). Self-reported comfort level in topics 35 days after the webinar increased by 11.3%, but this was not statistically significant (mean 3.36 pre- to 3.74 post, p = 0.1). Over six months, recordings were accessed 412 times. After six months, the second webinar had 93 participants from eight SSA countries. Membership in the DMP increased from 64 to 172; recordings were viewed 412 times in six months; and 113 participants from nine SSA countries completed surveys. Among 74 respondents who perform IHC, 43.5% reported moderate or significant positive practice changes such as improved antigen retrieval techniques and optimization of preanalytical variables. Over half (52.7%, n = 39) reported the quality of slides had moderately or significantly improved. After one year, a third webinar had 98 participants from eight SSA countries. Thirty-eight completed surveys, DMP membership increased to 199, and 1 reported launching IHC in a lab in Nigeria. Our program 1) reached hundreds of participants and provided a baseline assessment of pathology capacity across nine SSA countries; 2) created a novel mechanism to build pathology capacity and assess progress with this cohort; and 3) improved practices and the preparation of slides for over half performing manual IHC. After one year, interest was sustained. Tracking impact on diagnosis and treatment of BC in the region is needed long-term.

1 May 2022 in Annals of Plastic Surgery
Verified
Journal Article
Closed access
AFArtur Fahradyan
Artur Fahradyan
ALAlice Liu
Alice Liu
LTLesley Taylor
Lesley Taylor
VJVeronica Jones
Veronica Jones
WLWai-Yee Li
Wai-Yee Li
Background Patients with locally advanced invasive breast cancer (LABC) are often considered inoperable, because of the anticipated chest wall defect and need for complex reconstruction. We present a series of patients who underwent mastectomy with extensive skin resection and immediate chest wall reconstruction using a local thoracoabdominal advancement flap (TAAF). All patients were managed after surgery with an ERAS (Enhanced Recovery After Surgery) protocol, to decrease length of stay in hospital. We also present 1 patient who subsequently had satisfactory bilateral delayed breast reconstruction with pedicled latissimus dorsi myocutaneous flaps with prepectoral silicone implants. Methods This is a single-surgeon, single-institution retrospective chart review of patients with LABC who underwent mastectomy with skin resection and local TAAF from May 2017 to October 2019, with minimum 3-month follow-up. Results Thirteen patients met inclusion criteria. Twelve of 13 patients presented with stage III or IV invasive breast cancer, with skin involvement. The mean chest wall defect measured 248.7 cm2 (140–336 cm2; SD, 63.2 cm2), and all were successfully reconstructed with immediate local TAAF. There were no intraoperative complications, but 1 patient developed a postop hematoma. The mean hospital stay was 1.3 nights, with 9 patients (69.2%) staying less than 23 hours and 4 patients (30.8%) staying 2 nights. Nine patients (69.2%) underwent adjuvant therapy, beginning on average 32 days (13–55 days; SD, 13.1 days) after surgery. The mean follow-up time was 13.8 months (4.5–31.6 months; SD, 9.2 months). One patient underwent successful delayed bilateral breast reconstruction with pedicled latissimus dorsi myocutaneous flaps and silicone implant placement. Conclusions Our study demonstrates that reconstruction with local TAAF is an outpatient procedure that reliably provides durable, immediate chest wall coverage, after mastectomy in patients with LABC. This technique has a short operative time, low blood loss, and low complication rate, allowing timely adjuvant therapy. Using an ERAS postop protocol we were able to reduce mean hospital stay to 1.3 days. Compared with other described techniques of reconstruction, the additional scars and donor site morbidity are minimal, allowing for delayed breast reconstruction. We also present survival outcomes data on these surgically managed patients.

5 May 2022 in The Journal of Physician Assistant Education
Verified
Journal Article
Closed access
NCN. Beth Collier
N. Beth Collier
LTLeslie Taylor
Leslie Taylor

22 July 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SZSelemaye Zenebe
Selemaye Zenebe
TYTomas Yeheyis
Tomas Yeheyis
FTFikru Tadesse
Fikru Tadesse
BDBedilu Deribe
Bedilu Deribe
GGGezhagn Geresu
Gezhagn Geresu
BFBetty Ferrell
Betty Ferrell
Introduction: Human papillomavirus vaccine acceptance is influenced by the parental perceptions of the vaccine, but there are few related studies in Ethiopia, and most have focused on quantitative approaches. Therefore, this qualitative study intended to explore parental perceptions about the human papillomavirus vaccine acceptance. Objective: To explore the perceived facilitators and barriers against human papillomavirus among rural parents with eligible daughters in the Alle district, southern Ethiopia. Methods: A qualitative study using focus group discussion and in-depth interviews was conducted from April 25, 2023, to May 25, 2023, among eligible parents of daughters in the Alle district, southern Ethiopia. A convenience sample of 53 parents was recruited for focus group discussions, and 15 parents were purposely sampled for in-depth interviews. The data were collected by a semi-structured focus group discussion guide and in-depth interview questionnaires. The interview data were translated into English after transcription, and thematic analysis was done by Atlas software version 7.1.16. Results: Among the total participants, 66.2% were female parents and 60.2% were protestant religious followers. Findings were split between two major themes: perceived facilitators and barriers to human papillomavirus vaccine acceptance. The perceived facilitators identified were preventing cervical cancer, seeing it as an expression of parental role and responsibility, and believing in the recommendation of health professionals as facilitators of human papillomavirus vaccination. The identified perceived barriers to human papillomavirus vaccination included: a lack of awareness, a lack of reliable information sources, a lack of trust in the vaccine, misconceptions, fear of side effects, and cultural and religious factors affecting the acceptance of human papillomavirus vaccination. Conclusion: Parents identified various facilitators and barriers to accepting the human papillomavirus vaccine. Therefore, we recommend that the government and concerned institutions work in collaboration to address the identified challenges to improve the acceptance of human papillomavirus vaccination.

31 January 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ADAbel Desalegn Demeke
Abel Desalegn Demeke
BDBedilu Deribe
Bedilu Deribe
MGMartha Girma
Martha Girma
MGMuluken Gizaw
Muluken Gizaw
SGSefonias Getachew
Sefonias Getachew
LTLesley Taylor
Lesley Taylor
Introduction: Breast and cervical cancers are the most frequent and fatal cancers among women. Thus, early detection is necessary to improve the prognosis of affected women. However, in Ethiopia, the rates of screening remain alarmingly low. Objective: To assess the magnitude of screening attendance for breast or cervical cancer, as well as the factors that predict it, among women aged 30–49 years old in Gedeo Zone, South Ethiopia, in 2023. Method: A community-based cross-sectional study was conducted using a multi-stage cluster sampling technique. Data were collected using pretested, structured questionnaires by trained interviewers. Univariate and multivariate logistic regression models were employed to identify factors associated with screening attendance. Results: A total of 554 women participated in the study. Of them, 132 (23.8%) were screened for breast or cervical cancer. Higher age of 40–44 versus 45–49 years (adjusted odds ratio [AOR] 4.18 [95% CI 1.59, 10.9]), higher education status ([AOR] 5.49 [95% CI 2.01, 13.1]), having family or a friend with history of breast or cervical cancer ([AOR] 5.55 [95% CI 2.47, 12.5]), short anticipated time to seek help ([AOR] 4.66 [1.31, 11.7]), adequate health literacy ([AOR] 6.98 [95% CI 2.82,13.3]) and high self-efficacy ([AOR] 2.32 [95% CI 1.08, 4.96]) were positive factors with higher screening attendance. High response cost ([AOR] 0.19 95% CI [0.08, 0.50]) was a negative factor and associated with lower screening attendance. Conclusion and recommendation: The study found that only one in four women attended breast or cervical cancer screening. Screening uptake was better in women with higher education, health literacy, self-efficacy, and older age–similar to factors associated with other health seeking behavior. Interestingly, history of breast or cervical cancer in a friend or relative was also associated with higher uptake. This indicates that in addition to awareness campaigns, personal testimonials of survivors could encourage women to visit screening facilities.